On the recordApril 17, 2012
We need to reauthorize the user fees by the end of June to assure continuity at the FDA and increase predictability for America's medical innovators and job creators.
Source
congress.govEditor's note · Context
Burgess stresses urgency in reauthorizing user fees for FDA continuity.
Share
More from Michael Burgess
Dec 17, 2024
Last night the House Committee on Rules met to report a rule providing for consideration of H.R. 115, the Midnight Rules Relief Act under a closed rule. The rule provides for 1 hour of general debate equally divided between the chair and…
Sep 23, 2024
I thank Dr. Bucshon from Indiana for yielding me the time on such an important reauthorization that we are undertaking today. Mr. Speaker, 2018 was the last authorization for sickle cell research. Prior to that, it had been part of the…
Nov 13, 2024
Last week, the American people spoke forcefully against what we have seen for 4 years out of the Biden-Harris administration and their whole-of- government assault over individual freedom, economic prosperity, and limited government. For 4…
Dec 4, 2024
I thank you for that admonition. I will try to be careful to keep that in mind during my closing remarks. Mr. Speaker, I yield myself the balance of my time. Mr. Speaker, the gentleman from Massachusetts is correct. He has provided me…
Other voices in this conversation
